Jaclyn Roman, CRNA
Staff Affiliate - YNHHAbout
Titles
Staff Affiliate - YNHH
Departments & Organizations
- All Institutions
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Jaclyn Roman's published research.
Sergio Pecorelli, MD
Alessandro Santin, MD
Stefania Bellone, PhD
Publications
2006
Fertility-Preserving Repeated High-Dose Medroxyprogesterone Acetate (Mpa) Therapy For Patients With Endometrial Cancer
Santin A, Bandiera E, Comper F, Bellone M, Marizzoni S, Zanolini A, Palmieri M, Siegel E, Mckinney J, Thomas M, Hennings L, Roman J, Burnett A, Cannon M, Pecorelli S. Fertility-Preserving Repeated High-Dose Medroxyprogesterone Acetate (Mpa) Therapy For Patients With Endometrial Cancer. International Journal Of Gynecological Cancer 2006, 16: 612. DOI: 10.1136/ijgc-00009577-200610001-00047.Peer-Reviewed Original ResearchPhase I Dose Escalation Trial of Hpv16/18 E7-Pulsed Dendritic Cell Vaccination in Stage Ib-Iia Cervical Cancer Patients
Santin A, Bellone S, Palmieri M, Ravaggi A, Zanolini A, Roman J, Burnett A, Cannon M, Pecorelli S. Phase I Dose Escalation Trial of Hpv16/18 E7-Pulsed Dendritic Cell Vaccination in Stage Ib-Iia Cervical Cancer Patients. International Journal Of Gynecological Cancer 2006, 16: 699. DOI: 10.1136/ijgc-00009577-200610001-00348.Peer-Reviewed Original Research
2004
006 Gene Expression Fingerprint of Uterine Serous Papillary Carcinoma: Identification of Novel Molecular Markers for Uterine Serous Cancer Diagnosis and Therapy
Santin A, Bellone S, Cane' S, Palmieri M, Bignotti E, Anfossi S, Thomas M, Roman J, Kay H, Burnett A, O'Brien T, Cannon M, John S, Zhan F, Tian E, Pecorelli S. 006 Gene Expression Fingerprint of Uterine Serous Papillary Carcinoma: Identification of Novel Molecular Markers for Uterine Serous Cancer Diagnosis and Therapy. International Journal Of Gynecological Cancer 2004, 14: 2. DOI: 10.1136/ijgc-00009577-200409001-00006.Peer-Reviewed Original ResearchRestoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer
SANTIN A, BELLONE S, PALMIERI M, BOSSINI B, CANE S, BIGNOTTI E, ROMAN J, CANNON M, PECORELLI S. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer. International Journal Of Gynecological Cancer 2004, 14: 64-75. DOI: 10.1111/ijgc-00009577-200401000-00008.Peer-Reviewed Original ResearchConceptsCD8+ T cellsAdvanced ovarian cancerPeripheral blood lymphocytesAdvanced ovarian cancer patientsTumor-infiltrating lymphocytesTumor infiltrationOvarian cancer patientsCytotoxic T lymphocytesDendritic cell stimulationOvarian cancerT cellsLymphoblastoid cell linesInfiltrating lymphocytesDendritic cellsKilling of autologous tumor cellsTumor-specific cytotoxic T lymphocytesTumor-specific T-cell responsesAnti-HLA class I mAbCD8+ T cell populationsCancer patientsAutologous ovarian cancer cellsAutologous tumor target cellsCD8+ CTL responsesLevels of CD56 expressionTumor antigen-loaded DC